US Patent 10550105 Pyridazinones as PARP7 inhibitors
Patent 10550105 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10550105 Pyridazinones as PARP7 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
